当前位置： SCI文献检索 > Asia-Pacific Journal of Clinical Oncology期刊下所有文献 > Prevalence of autoimmune hemolytic anemia in multiple myeloma: A prospective study.

Prevalence of autoimmune hemolytic anemia in multiple myeloma: A prospective study.

Abstract：

AIM:Autoimmune hemolytic anemia (AIHA) is frequently associated with B-cell lymphoproliferative disorders, and patients rarely develop overt clinical manifestations of AIHA. AIHA is rare in patients with multiple myeloma (MM). We conducted a prospective study to detect the presence of AIHA in MM patients and its impact on clinical presentation and outcome of the disease. METHODS:Sixty-six patients were diagnosed to have MM. Seventeen of these patients who had severe anemia (hemoglobin < 6 g/dL) requiring frequent blood transfusions with or without features of hemolysis were screened for AIHA by performing direct and indirect antiglobulin (Coombs') test. RESULTS:Seven (10.6%) of these 17 patients were found to be complicated with AIHA and carried autoantibodies in their sera. Five patients had de novo MM and two had relapsed MM. Six patients (85.7%) had stage IIIA disease and one (14.3%) had stage IIIB disease. The IgG subclass of the antibody binding to red cell membrane was compared with that of M-protein and these findings showed full correlation in all the seven patients. All of these patients were positive for subtypes of IgG and one patient had simultaneous positivity for IgA and IgG2, with presence of cold antibodies in the serum. Patients with primary disease showed remission of AIHA with therapy, whereas both the patients with relapsed disease showed no response to treatment and remained positive for antiglobulin test. CONCLUSION:AIHA should be suspected in MM patients with severe anemia requiring frequent blood transfusions.

journal_name

Asia Pac J Clin Oncol

journal_title

Asia-Pacific journal of clinical oncology

authors

Kashyap R,Singh A,Kumar P

doi

10.1111/ajco.12230

subject

Has Abstract

pub_date

2016-06-01 00:00:00

pages

e319-22

issue

2

eissn

1743-7555

issn

1743-7563

journal_volume

12

pub_type

杂志文章

相关文献

Asia-Pacific Journal of Clinical Oncology文献大全
  • Effect of pre existing respiratory conditions on survival of lung cancer patients: A nationwide population-based cohort study.

    abstract：BACKGROUND:Common diseases with potential to increase the risk of death from lung cancer have so far not been studied in large populations. METHODS:We did a population-based retrospective cohort study using nationwide health insurance claims data from 2005 to 2012 in Korea including 205 403 lung cancer patients. Multi...

    journal_title：Asia-Pacific journal of clinical oncology

    pub_type： 杂志文章

    doi：10.1111/ajco.12697

    authors： Hong S,Park EC,Kim TH,Kwon JA,Yoo KB,Han KT,Yoo JW,Kim SJ

    更新日期：2018-04-01 00:00:00

  • Clinical application of a rapid cervical cancer screening method: Folate receptor-mediated staining of cervical neoplastic epithelia.

    abstract：AIM:A newly developed cervical cancer screening method - folate receptor-mediated epithelium staining utilizes methylene blue internalized by folate receptor-mediated endocytosis to stain cervical intra-epithelial neoplasia. We test the clinical feasibility of this method in this study. METHODS:A total of 14 344 women...

    journal_title：Asia-Pacific journal of clinical oncology

    pub_type： 杂志文章

    doi：10.1111/ajco.12573

    authors： Li D,Chen L,Wang H,Yang H,Dai Y,Yu C,Dong Y

    更新日期：2017-02-01 00:00:00

  • Upfront maintenance therapy with arsenic trioxide in acute promyelocytic leukemia provides no benefit for non-t(15;17) subtype.

    abstract：AIMS:The optimal maintenance therapy for patients with acute promyelocytic leukemia (APL) who achieved complete remission (CR) and complete consolidation chemotherapy is still controversial. Whether the use of arsenic trioxide (ATO) alone or along with all-trans retinoic acid (ATRA) improves overall survival (OS) or di...

    journal_title：Asia-Pacific journal of clinical oncology

    pub_type： 杂志文章

    doi：10.1111/j.1743-7563.2011.01496.x

    authors： Chiang YH,Chang YF,Hsieh RK,Lin J,Chen CG,Lim KH,Lin HC,Chang MC

    更新日期：2012-12-01 00:00:00

  • Result of extracorporeal irradiation and re-implantation for malignant bone tumors: a review of 30 patients.

    abstract：AIMS:Extracorporeal irradiation and re-implantation (ECI) has been used as limb salvage surgery for musculoskeletal oncology patients. Biological reconstruction, no risk of disease transmission and immunological reaction, ready availability and preservation of bone stock are the major advantage of this surgical techniq...

    journal_title：Asia-Pacific journal of clinical oncology

    pub_type： 杂志文章

    doi：10.1111/ajco.12036

    authors： Arpornchayanon O,Leerapun T,Pruksakorn D,Panichkul P

    更新日期：2013-09-01 00:00:00

  • Toxicity profile differences of adjuvant docetaxel/cyclophosphamide (TC) between Asian and Caucasian breast cancer patients.

    abstract：AIM:For early-stage breast cancer, four cycles of docetaxel and cyclophosphamide (TC) was proven superior to doxorubicin plus cyclophosphamide in the US Oncology 9375 trial. Given primary prophylactic antibiotics, 5% febrile neutropenia was recorded in a population comprising 75.5% Caucasians. Smaller trials and retros...

    journal_title：Asia-Pacific journal of clinical oncology

    pub_type： 杂志文章

    doi：10.1111/ajco.12682

    authors： Chow LWC,Biganzoli L,Leo AD,Kuroi K,Han HS,Patel J,Huang CS,Lu YS,Zhu L,Chow CYC,Loo WTY,Glück S,Toi M

    更新日期：2017-12-01 00:00:00

  • Phase II APEC trial: The impact of primary tumor side on outcomes of first-line cetuximab plus FOLFOX or FOLFIRI in patients with RAS wild-type metastatic colorectal cancer.

    abstract：AIM:The open-label, nonrandomized, phase II APEC study enrolled 167 patients with RAS wild-type (wt) metastatic colorectal cancer (mCRC) to investigate the safety and efficacy of first-line, every-2-weeks cetuximab plus investigator's choice of FOLFIRI or FOLFOX in this patient population. METHODS:A subgroup analysis ...

    journal_title：Asia-Pacific journal of clinical oncology

    pub_type： 杂志文章

    doi：10.1111/ajco.13154

    authors： Price T,Shen L,Ma B,Esser R,Chen W,Gibbs P,Lim R,Cheng AL

    更新日期：2019-08-01 00:00:00

  • Examining clinicians' perceptions of head and neck cancer (HNC) information.

    abstract：BACKGROUND:Providing appropriate educational resources to patients with head and neck cancer (HNC) is important but challenging. The aim of this study was to determine Australian clinicians' perceptions of currently used HNC information resources. METHODS:A purpose-designed questionnaire was disseminated electronicall...

    journal_title：Asia-Pacific journal of clinical oncology

    pub_type： 杂志文章

    doi：10.1111/ajco.12858

    authors： Jabbour J,Wykes J,Milross C,Sundaresan P,Ebrahimi A,Shepherd HL,Dhillon HM,Clark JR

    更新日期：2018-10-01 00:00:00

  • Efficacy and safety of sorafenib in combination with gemcitabine in patients with advanced hepatocellular carcinoma: a multicenter, open-label, single-arm phase II study.

    abstract：AIMS:Currently, the only standard systemic treatment for advanced hepatocellular carcinoma is sorafenib monotherapy. The study was conducted to assess the efficacy and safety of the novel combination of sorafenib and gemcitabine in the treatment of advanced hepatocellular carcinoma. METHODS:Between March 2008 and Octo...

    journal_title：Asia-Pacific journal of clinical oncology

    pub_type： 杂志文章,多中心研究

    doi：10.1111/ajco.12191

    authors： Srimuninnimit V,Sriuranpong V,Suwanvecho S

    更新日期：2014-09-01 00:00:00

  • Real-world impact of anti-HER2 therapy-related cardiotoxicity in patients with advanced HER2-positive breast cancer.

    abstract：BACKGROUND:Anti-HER2 therapy-related cardiotoxicity is well described in the context of clinical trials, particularly in the setting of early stage disease, but there is more limited data in advanced breast cancer and in the real world setting. MATERIAL AND METHODS:A prospectively-maintained registry database with 312...

    journal_title：Asia-Pacific journal of clinical oncology

    pub_type： 杂志文章

    doi：10.1111/ajco.13381

    authors： Conduit C,de Boer RH,Lok S,Gibbs P,Malik L,Loh Z,Yeo B,Greenberg S,Devitt B,Lombard J,Nottage M,Collins I,Torres J,Nolan M,Nott L

    更新日期：2020-12-01 00:00:00

  • Additional chemotherapy and salvage surgery for poor response to chemoradiotherapy in rectal cancers.

    abstract：AIM:A proportion of locally advanced rectal cancer patients who receive neoadjuvant chemoradiotherapy (NACRT) are still unresectable. This study was undertaken to assess the outcomes of giving additional chemotherapy to rectal cancer patients with unresectable disease after NACRT. METHODS:Patients with poor response t...

    journal_title：Asia-Pacific journal of clinical oncology

    pub_type： 杂志文章

    doi：10.1111/ajco.12660

    authors： Engineer R,Ostwal V,Arya S,Gupta P,Chopra S,Patil P,Jatal S,Saklani A

    更新日期：2017-08-01 00:00:00

  • Neutrophil count kinetics during the first cycle of chemotherapy predicts the outcome of patients with locally advanced or metastatic pancreatic cancer.

    abstract：BACKGROUND:Neutrophil count reduction after chemotherapy has been related with longer survival of patients with metastatic pancreatic adenocarcinoma, but there is not a standardized measurement for this phenomenon. METHODS:Some parameters related to the change in neutrophil count between the first and the second cycle...

    journal_title：Asia-Pacific journal of clinical oncology

    pub_type： 杂志文章

    doi：10.1111/ajco.13325

    authors： Colloca GA,Venturino A,Guarneri D

    更新日期：2020-08-01 00:00:00

  • Acute inflammatory demyelinating polyradiculoneuropathy in a patient receiving oxaliplatin-based chemotherapy.

    abstract：:We report a case of acute inflammatory demyelinating polyradiculoneuropathy (AIDP) that developed in a patient with cholangiocarcinoma after receiving oxaliplatin-based chemotherapy. A 62-year-old man had multiple hypodense lesions with delayed enhancement in the both lobes of the liver on abdominal computed tomograph...

    journal_title：Asia-Pacific journal of clinical oncology

    pub_type： 杂志文章

    doi：10.1111/j.1743-7563.2011.01515.x

    authors： Yoon JY,Nam TS,Kim MK,Hwang JE,Shim HJ,Cho SH,Chung IJ,Bae WK

    更新日期：2012-06-01 00:00:00

  • KRAS mutation testing of metastatic colorectal cancer in Australia: where are we at?

    abstract：AIM:To carry out a nationwide study of KRAS testing in metastatic colorectal cancer as reported by nine major molecular pathology service providers in Australia, including mutation frequencies and turnaround times that might impact on patient care. METHODS:Participating laboratories contributed information on KRAS mut...

    journal_title：Asia-Pacific journal of clinical oncology

    pub_type： 杂志文章

    doi：10.1111/ajco.12201

    authors： Scott RJ,Fox SB,Desai J,Grieu F,Amanuel B,Garrett K,Harraway J,Cheetham G,Pattle N,Haddad A,Byron K,Rudzki B,Waring P,Iacopetta B

    更新日期：2014-09-01 00:00:00

  • Different genetic alteration of A20 in a Sézary syndrome case with Vα2-Jα22 T cell clone.

    abstract：BACKGROUND:The comprehensive genetic alterations underlying the pathogenesis of Sézary syndrome (SS) remains largely unknown. Previous studies showed that alterations of tumor necrosis factor-α-induced protein 3 gene (TNFAIP3; A20) are frequent in SS. In this study, we characterized the mutation and polymorphisms of A2...

    journal_title：Asia-Pacific journal of clinical oncology

    pub_type： 杂志文章

    doi：10.1111/ajco.12672

    authors： Zhou L,Zheng H,Huang X,Zhu L,Wu S,Zeng C,Yang L,Chen S,Luo G,Du X,Li Y

    更新日期：2018-04-01 00:00:00

  • The prognostic value of aspartate aminotransferase-to-lymphocyte ratio index in early-stage hepatocellular carcinoma after hepatectomy: A propensity-score matched analysis.

    abstract：BACKGROUND:An elevated preoperative aspartate aminotransferase-to-lymphocyte ratio index (ALRI) may predict poor survival in various cancers. However, the prognostic value of aminotransferase-to-lymphocyte ratio index (ALRI) in patients with hepatocellular carcinoma (HCC) remains to be determined. MATERIALS AND METHOD...

    journal_title：Asia-Pacific journal of clinical oncology

    pub_type： 杂志文章

    doi：10.1111/ajco.13458

    authors： Chen Y,He C,Wen T,Yan L,Yang J

    更新日期：2020-10-30 00:00:00

  • Effectiveness of image-guided radiotherapy for rectal cancer patients treated with neoadjuvant concurrent chemoradiotherapy: A population-based propensity score-matched analysis.

    abstract：AIM:The effects of image-guided radiotherapy (IGRT, an advanced RT technology) have been debated in the literature. We compared the outcomes of locally advanced rectal cancer (LARC) patients treated with neoadjuvant concurrent chemoradiotherapy (NCCRT; with vs without IGRT) in a large population-based propensity score ...

    journal_title：Asia-Pacific journal of clinical oncology

    pub_type： 杂志文章

    doi：10.1111/ajco.13196

    authors： Li CC,Liang JA,Chen WT,Chien CR

    更新日期：2019-10-01 00:00:00

  • Differentiating malignant colorectal tumor patients from benign colorectal tumor patients by assaying morning urinary arylsulfatase activity.

    abstract：AIM:For several decades urinary arylsulfatase (ARS) activity has been reported to be elevated in many cancers. It has been shown that urinary ARS activity may serve as a marker of tumor progression and therapy surveillance. This study was designed to evaluate the clinical application of detection of urinary ARS activit...

    journal_title：Asia-Pacific journal of clinical oncology

    pub_type： 杂志文章

    doi：10.1111/j.1743-7563.2012.01545.x

    authors： Niu R,Jing H,Chen Z,Xu J,Dai J,Yan Z

    更新日期：2012-12-01 00:00:00

  • Posterior reversible encephalopathy syndrome following chemotherapy with oxaliplatin and a fluoropyrimidine: a case report and literature review.

    abstract：:Posterior reversible encephalopathy syndrome (PRES) is a neuro-radiological syndrome characterized by seizures, altered level of consciousness and visual disturbance. PRES is associated with hyperintense lesions on magnetic resonance imaging (MRI) most commonly seen in the posterior regions. In most cases symptoms and...

    journal_title：Asia-Pacific journal of clinical oncology

    pub_type： 杂志文章,评审

    doi：10.1111/j.1743-7563.2012.01544.x

    authors： Femia G,Hardy TA,Spies JM,Horvath LG

    更新日期：2012-06-01 00:00:00

  • Pre-treatment serum lactate dehydrogenase as a biomarker in small cell lung cancer.

    abstract：BACKGROUND:Small cell lung cancer is a rapidly progressive disease with high fatality. No sensitive and specific biomarker to assist in managing this disease exists currently. AIM:Role of pretreatment serum lactate dehydrogenase as a biomarker in small cell lung cancer. METHODS:A hospital-based cancer registry was us...

    journal_title：Asia-Pacific journal of clinical oncology

    pub_type： 杂志文章

    doi：10.1111/ajco.12674

    authors： Hsieh AH,Tahkar H,Koczwara B,Kichenadasse G,Beckmann K,Karapetis C,Sukumaran S

    更新日期：2018-04-01 00:00:00

  • Clinical features and long-term outcomes of bilateral Wilms tumor treated with Taiwan Pediatric Oncology Group protocols: A single center report.

    abstract：AIMS:Wilms tumor (WT) is rare in Asia. Treatment of bilateral WT is challenging, and the treatment outcome of bilateral WT is rarely reported in low incidence areas. METHODS:We enrolled patients with bilateral WT registered in Chang Gung Memorial Hospital, Taoyuan, Taiwan, between January 1986 and June 2015. They were...

    journal_title：Asia-Pacific journal of clinical oncology

    pub_type： 杂志文章

    doi：10.1111/ajco.12501

    authors： Chen SH,Hung IJ,Yang CP,Jaing TH,Wang CJ,Hsueh C,Lai JY

    更新日期：2016-09-01 00:00:00

  • Cancer in Pregnancy.

    abstract：:Cancer in pregnancy may be increasing in incidence with advancing maternal age and higher rates of obesity. The diagnosis of cancer in pregnancy provokes complex management issues balancing short- and long-term risks for both mother and baby. Every case needs to be individualized, with a multidisciplinary team of midw...

    journal_title：Asia-Pacific journal of clinical oncology

    pub_type： 杂志文章,评审

    doi：10.1111/ajco.13235

    authors： Eastwood-Wilshere N,Turner J,Oliveira N,Morton A

    更新日期：2019-12-01 00:00:00

  • A phase I and II trial of epirubicin, cisplatin, 24-hour infusion 5 fluorouracil and sodium folinate in patients with advanced esophagogastric carcinomas.

    abstract：AIM:Advanced esophagogastric carcinoma has a poor prognosis. Palliative chemotherapy provides a survival advantage and improved quality of life. Epirubicin, cisplatin and continuous infusional 5-fluorouracil (5-FU) (ECF) is a well-established chemotherapy regimen but a continuous chemotherapy infusion is not always fea...

    journal_title：Asia-Pacific journal of clinical oncology

    pub_type： 杂志文章

    doi：10.1111/j.1743-7563.2010.01340.x

    authors： Karapetis CS,Cheong KA,Yip D,Strickland AH,Steer C,Marx G,Yip S,Chrystal K,Harper PG

    更新日期：2010-12-01 00:00:00

  • Afatinib for an EGFR exon 20 insertion mutation: A case report of progressive stage IV metastatic lung adenocarcinoma with 54 months' survival.

    abstract：:Non-small cell lung cancers (NSCLC) harboring the uncommon epidermal growth factor receptor (EGFR) exon 20 insertion mutations are generally thought to be unresponsive to EGFR-tyrosine kinase inhibitor (TKI) therapy. Presented here is a case of stage IV NSCLC harboring an uncommon EGFR exon 20 insertion mutation that ...

    journal_title：Asia-Pacific journal of clinical oncology

    pub_type： 杂志文章

    doi：10.1111/ajco.12853

    authors： Chan RT

    更新日期：2018-03-01 00:00:00

  • Postoperative radiotherapy improves overall survival in patients with primary squamous cell carcinoma of the breast.

    abstract：BACKGROUND:Primary squamous cell carcinoma of the breast (PSCCB) is a rare clinical classification of breast tumors. Little is known about its clinicopathological features, prognosis and potential therapeutic strategies. The purpose of this study is to evaluate the effect of postoperative radiotherapy (PORT) on patient...

    journal_title：Asia-Pacific journal of clinical oncology

    pub_type： 杂志文章

    doi：10.1111/ajco.13466

    authors： Wang X,Zhang L,Luo J,Jin K,Yang Z,Meng J,Zhang X,Zhang Z,Shao Z,Guo X,Chen X,Yu X

    更新日期：2020-10-20 00:00:00

  • Significance of methylation status of MASPIN gene and its protein expression in prognosis of gallbladder cancer.

    abstract：AIM:We investigated prognostic significance of methylation status of MASPIN gene and its protein expression in normal subjects, cholelithiasis and gallbladder cancer (GBC) patients. METHODS:MASPIN protein expression and its promoter methylation in gallbladder tissue of cholelithiasis (n = 36), GBC (n = 46) and control...

    journal_title：Asia-Pacific journal of clinical oncology

    pub_type： 杂志文章

    doi：10.1111/ajco.13129

    authors： Baghel K,Kazmi HR,Chandra A,Raj S,Srivastava RN

    更新日期：2019-10-01 00:00:00

  • Systemic treatment in advanced biliary cancers: A multicenter Australian analysis and review.

    abstract：AIM:While first-line palliative chemotherapy (CT1) improves survival and quality of life in advanced biliary cancer (ABC), there is no randomized evidence to support second-line chemotherapy (CT2) in ABC. We aim to explore to role of CT2 in ABC. METHODS:We performed a retrospective review of all patients who received ...

    journal_title：Asia-Pacific journal of clinical oncology

    pub_type： 杂志文章,多中心研究,评审

    doi：10.1111/ajco.12638

    authors： Brungs D,Aghmesheh M,Sjoquist K,Goldstein D

    更新日期：2017-10-01 00:00:00

  • Patient outcomes of whole brain radiotherapy for brain metastases versus leptomeningeal metastases: A retrospective study.

    abstract：AIM:Important factors typically associated with prognosis in brain metastases include Karnofsky performance status (KPS), extracranial or cerebellar localization and combination chemotherapy. However, few studies investigated the prognostic role of leptomeningeal metastases (LM) following whole brain radiotherapy (WBRT...

    journal_title：Asia-Pacific journal of clinical oncology

    pub_type： 杂志文章

    doi：10.1111/ajco.12597

    authors： Sakaguchi M,Maebayashi T,Aizawa T,Ishibashi N,Saito T

    更新日期：2017-10-01 00:00:00

  • Longitudinal validation and comparison of the Chinese version of the European Organization for Research and Treatment of Cancer Quality of Life-Chemotherapy-Induced Peripheral Neuropathy Questionnaire (EORTC QLQ-CIPN20) and the Functional Assessment of Ca

    abstract：AIM:To validate and compare the Chinese version of the European Organization for Research and Treatment of Cancer Quality of Life-Chemotherapy-Induced Peripheral Neuropathy Questionnaire (EORTC QLQ-CIPN20) and the Functional Assessment of Cancer-Gynecologic Oncology Group-Neurotoxicity subscale (FACT/GOG-Ntx) for measu...

    journal_title：Asia-Pacific journal of clinical oncology

    pub_type： 杂志文章,多中心研究

    doi：10.1111/ajco.13000

    authors： Cheng HL,Molassiotis A

    更新日期：2019-02-01 00:00:00

  • A multicenter, observational study of metastatic breast cancer patients who were treated with eribulin mesylate or taxane-based regimens.

    abstract：AIM:This multicenter, observational study aimed to investigate the survival benefit of eribulin as well as that of taxane-based regimens in Japanese patients with metastatic breast cancer (MBC) in a real-world setting. METHODS:This study enrolled women with MBC who received eribulin or taxane-based regimens with or wi...

    journal_title：Asia-Pacific journal of clinical oncology

    pub_type： 杂志文章,多中心研究

    doi：10.1111/ajco.12863

    authors： Kikuchi Y,Uchida Y,Shirakawa K,Kanauchi H,Niwa T,Nishioka K,Tada K,Hashimoto M,Yasuda H,Sugiura R,Kawabata H,Seto Y,Ogawa T

    更新日期：2018-10-01 00:00:00

  • Infliximab for ipilimumab-induced colitis: A series of 13 patients.

    abstract：OBJECTIVE:To review the outcomes of metastatic melanoma patients treated with infliximab for severe steroid-refractory colitis secondary to ipilimumab therapy. BACKGROUND:Immune-related colitis is a known potential adverse effect of ipilimumab, that causes significant morbidity and extended hospital stays. There are l...

    journal_title：Asia-Pacific journal of clinical oncology

    pub_type： 杂志文章

    doi：10.1111/ajco.12651

    authors： Hillock NT,Heard S,Kichenadasse G,Hill CL,Andrews J

    更新日期：2017-10-01 00:00:00